-       Clinical Trials 
- April 2025
-  60 Pages 
- Global 
   From       €894EUR$1,000USD£787GBP 
      €1118EUR$1,250USD£983GBP 
             The West Nile Drug market is a subset of the larger Infectious Diseases Drugs market. It is composed of drugs used to treat West Nile Virus (WNV), a mosquito-borne virus that can cause severe neurological symptoms. The market is composed of both generic and branded drugs, with the majority of sales coming from branded drugs. The market is highly competitive, with a number of companies offering similar products.
The market is driven by the increasing prevalence of WNV, as well as the need for more    effective treatments. As the virus continues to spread, the demand for drugs to treat it is expected to increase.
Companies in the West Nile Drug market include Sanofi, GlaxoSmithKline, Merck, Pfizer, and Novartis. Show Less   Read more